Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Automated Drug Compounding Systems Market Size Forecast: How Large Could The Market Become By 2030?
In recent years, the automated drug compounding systems market size has seen rapid growth. This market is expected to increase from $1.85 billion in 2025 to $2.08 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.3%. The expansion observed in previous periods is attributable to the increasing uptake of automated systems in hospital pharmacies, the growing imperative to minimize medication errors, a heightened focus on sterile and precise drug preparation, the increasing workload for pharmacy staff, and the rising demand for time-efficient compounding processes.
The automated drug compounding systems market size is projected for substantial expansion in the coming years. This market is anticipated to reach $3.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.0%. This forecasted expansion is linked to factors such as increased investment in healthcare automation, greater integration of software and automated instruments, the escalating demand for uniformity in drug compounding, a heightened emphasis on minimizing contamination hazards, rising hospital expenditure on automation infrastructure, and the growing requirement for enhanced operational efficiency within pharmacies. Significant developments expected during this period encompass progress in robotic-assisted drug compounding technologies, advancements in software integration for managing pharmacies, the incorporation of artificial intelligence to reduce errors in compounding procedures, enhancements in real-time monitoring and quality control systems, and novel approaches in automated sterile compounding methods.
Download A Free Sample Report For Comprehensive Market Insights:
#Automated Drug Compounding Systems Market Growth Factors: Which Forces Are Supporting Market Expansion?
The anticipated expansion of the automated drug compounding systems market is linked to the rising occurrence of chronic diseases. These are enduring health issues, such as diabetes, heart disease, and arthritis, that typically advance slowly and demand continuous medical care and lifestyle adjustments for symptom control and complication prevention. The growth in chronic diseases is largely attributable to unhealthy lifestyle choices, including poor diet, lack of physical activity, and smoking, which heighten the risk of conditions like diabetes, heart disease, and obesity. Automated drug compounding systems assist in managing chronic conditions by accurately preparing custom medications suited to individual patient requirements. They enhance the precision and uniformity of treatment, thereby minimizing errors and improving long-term therapeutic results. For example, in June 2024, data from the National Health Service, a UK-based government department, showed that 3,615,330 people registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% rise from 3,065,825 cases in 2022. Consequently, the growing incidence of chronic diseases is a key factor propelling the automated drug compounding systems market. The scarcity of qualified pharmacy personnel is anticipated to boost the expansion of the automated drug compounding systems market in the coming years. This deficit pertains to the restricted availability of pharmacists and technicians trained to safely prepare and dispense medications across various healthcare settings like hospitals, clinics, and compounding pharmacies. The increasing shortage of skilled pharmacy staff stems from growing patient volumes and the rising incidence of chronic diseases that necessitate meticulous pharmaceutical care. Automated drug compounding systems decrease dependency on human pharmacy staff by facilitating the precise, consistent, and efficient preparation of medications with minimal manual involvement, thereby lowering the chances of errors and easing the workload for pharmacy teams. For example, in August 2024, the National Center for Health Workforce Studies, a US-based health workforce research organization, forecasted a deficit of 4,980 pharmacists over the next 15 years, extending to 2036, even as the overall demand for pharmacists is predicted to increase by 3% from 2022 to 2032, highlighting concerns amidst declining application rates. Hence, the shortage of skilled pharmacy staff is a significant factor driving the growth of the automated drug compounding systems market.
Automated Drug Compounding Systems Market Segmentation Trends And Revenue Drivers
The automated drug compounding systems market covered in this report is segmented –
1) By Product: Robotic Compounding Systems, Automated Liquid Compounding Systems, Tablet And Capsule Dispensers, Injectable Compounding Robots, IV Admixture Systems, Oral Liquid Compounding Systems
2) By Component: Equipment, Software, Consumables, Services
3) By Technology: Robotic-Based Systems, Semi-Automated Systems, Gravimetric Dosing Systems, Volumetric Dosing Systems, Hybrid Dosing Systems
4) By End-User: Hospitals, Clinics, Retail Pharmacies, Compounding Pharmacies, Pharmaceutical Manufacturers
Subsegments:
1) By Robotic Compounding Systems: Fully Automated Sterile Compounding Robots, Hazardous Drug Compounding Robots, Non-Hazardous Drug Compounding Robots, High-Throughput Pharmacy Robots, Closed-System Robotic Compounding Units
2) By Automated Liquid Compounding Systems: Large-Volume Parenteral (LVP) Compounding Systems, Small-Volume Parenteral (SVP) Compounding Systems, Multi-Drug Liquid Compounding Units, Volumetric And Gravimetric Liquid Compounding Systems, Pediatric Liquid Dosing Compounding Systems
3) By Tablet and Capsule Dispensers: Automated Tablet Counting Dispensers, Unit-Dose Packaging Systems, Multi-Dose Blister Dispensing Units, Capsule Filling and Dispensing Systems, High-Speed Pharmacy Dispensing Robots
4) By Injectable Compounding Robots: Chemotherapy Drug Compounding Robots, TPN (Total Parenteral Nutrition) Compounding Robots, High-Precision Syringe Preparation Robots, Sterile Injectable Filling Robots, Hazardous Injectable Handling Systems
5) By IV Admixture Systems: Automated IV Bag Filling Systems, IV Nutrition (TPN) Admixture Systems, IV Antibiotic Admixture Devices, Pharmacy Cleanroom IV Automation Units, Closed-System IV Compounding Systems
6) By Oral Liquid Compounding Systems: Pediatric Oral Liquid Compounding Machines, Flavoring & Suspension Mixing Systems, Multi-Ingredient Oral Liquid Compounding Units, Gravimetric Oral Solution Compounding Systems, Low-Volume Oral Dosing Compounding Systems
Automated Drug Compounding Systems Market Industry Trends: What Changes Are Reshaping Demand?
Major companies in the automated drug compounding systems market are focusing on developing advanced solutions, such as total parenteral nutrition (TPN) automation systems, to boost accuracy, safety, and efficiency in producing personalized intravenous formulations. A total parenteral nutrition (TPN) automation system functions as a compounding platform that not only automates the mixing and dispensing of total parenteral nutrition (TPN) solutions but also integrates prescription validation and workflow management tools to minimize human error and ensure sterile, high-quality preparation. For example, in May 2025, MediServ Co. Ltd., launched the APEX TPN Compounding System in Riyadh, initiating a new era of precision and automation for parenteral nutrition workflows. The system, presented with its EasyComp integration software, enhances the total parenteral nutrition (TPN) process by linking validated prescriptions directly to sterile, accurate compounding, thereby streamlining pharmacy operations and reducing manual tasks.
#Automated Drug Compounding Systems Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the automated drug compounding systems market are Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc., Omnicell Inc., Eckert & Ziegler SE, Swisslog Healthcare AG, EQUASHIELD Medical Ltd., Trasis S.A., Loccioni Group S.p.A., ARxIUM Inc., Comecer S.p.A., Tema Sinergie S.p.A., Epic Medical Pte. Ltd., IBA Radiopharma Solutions S.A., Steriline S.r.l., Elysia-Raytest GmbH, Curifylabs OY, Kapsam Health Solutions Pvt. Ltd.
Access The Complete Automated Drug Compounding Systems Market Report:
Automated Drug Compounding Systems Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the automated drug compounding Systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated drug compounding systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model